Loading term…
The EU official document describing a medicinal product's properties and approved conditions of use, serving as the basis for healthcare professional information.
The SmPC Section 4.8 lists 'Very common (≥1/10): headache; Common (≥1/100): nausea' providing expectedness reference and frequency information for adverse reactions.
EU Directive 2001/83/EC
Using the US PI for EU expectedness assessment or vice versa. Regional documents must be used for their respective regions.
Do you maintain current SmPCs for all your EU-marketed products? How do you track updates?